NewAmsterdam Pharma Company NV (NASDAQ: NAMS) is -23.31% lower on its value in year-to-date trading and has touched a low of $15.19 and a high of $27.29 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NAMS stock was last observed hovering at around $17.88 in the last trading session, with the day’s gains setting it 1.83%.
Currently trading at $19.71, the stock is -1.09% and -13.77% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.07 million and changing 10.23% at the moment leaves the stock -0.33% off its SMA200. NAMS registered -14.82% loss for a year compared to 6-month gain of 21.22%.
The stock witnessed a -12.83% loss in the last 1 month and extending the period to 3 months gives it a -2.04%, and is 3.09% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.99% over the week and 6.38% over the month.
Distance from 52-week low is 29.76% and -27.78% from its 52-week high.
The EPS is expected to shrink by -7.38% this year
The shares outstanding are 92.17M, and float is at 55.12M with Short Float at 5.08%.
The top institutional shareholder in the company is FRAZIER LIFE SCIENCES MANAGEMENT, L.P. with over 12.23 million shares valued at $$234.88 million. The investor’s holdings represent 12.9097 of the NAMS Shares outstanding. As of 2024-06-30, the second largest holder is FCPM III SERVICES B.V. with 11.83 million shares valued at $$227.28 million to account for 12.4921 of the shares outstanding. The other top investors are BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC which holds 10.47 million shares representing 11.0587 and valued at over $$201.2 million, while RA CAPITAL MANAGEMENT, L.P. holds 8.5143 of the shares totaling 8.06 million with a market value of $$154.91 million.
NewAmsterdam Pharma Company NV (NAMS) Insider Activity
Still, SEC filings show that on Jan 10 ’25, NAP PoolCo B.V. (Affiliate) Proposed Sale 1,396,241 shares at an average price of $25.31 for $35.34 million. The insider now directly holds shares of NewAmsterdam Pharma Company NV (NAMS).
